Intraperitoneal injection of slime glycolipoprotein (GLP) from Pseudomonas aeruginosa induced leukopenia and death of mice, similar to the effect of infection with viable organisms. Differential counts established that the leukopenia was characterized by a decrease in the number of polymorphonuclear leukocytes, followed by death of mice. Mice immunized with GLP survived challenge and responded with a leukocytosis that had a substantial increase in circulating polymorphonuclear leukocytes. Leukocytes from GLP-injected mice were agglutinated by anti-GLP serum, indicating an association between GLP and leukocytes. Other results indicated that 14C-labeled GLP is deposited mainly in the liver. Normal leukocytes labeled with 51Cr were injected intravenously into mice receiving an intraperitoneal injection of GLP. As with GLP, the 5'Crlabeled leukocytes were sequestered in the liver. These results indicate that GLP enters the blood stream and becomes associated mainly with neutrophils, and that the neutrophil-GLP complex is deposited in the liver, possibly accounting for the leukopenia in mice.Although infections resulting from Pseudomonas aeruginosa have been studied for many years, relatively little is known about its pathogenesis. Several possible virulence factors have been characterized, such as: proteases (11), exotoxin or toxin A (4, 12), leukocidin (13-16), and slime (1,8,18,19). The glycolipoprotein (GLP) fraction, extracted from the slime layer, has been observed to induce leukopenic and lethal effects in mice, much the same as infection with viable organisms. Active and passive immunization against highly purified GLP protected mice from leukopenia and death after challenge with live organisms (18). The production of GLP has been detected in vivo after injection of live organisms, as well as its dissemination via the peripheral blood circulation to become associated with erythrocytes (8).In this study, the GLP-induced leukopenic effect was further characterized, and the relationship between GLP and blood leukocytes was examined. The distribution of GLP in mouse organs was also determined.
MATERIALS AND METHODSOrganism. The bacterium used in this study, P. aeruginosa strain BI, was originally isolated from a clinical specimen and was described previously (2). GLP. The GLP fraction was obtained from the extracellular slime layer of strain BI and was purified by the method described by Sensakovic and Bartell (18). Purified GLP was injected into mice intraperitoneally at a concentration of 50 pugIg as a challenge. This concentration represented 2 mean lethal doses and was usually lethal to 100% of the mice injected.Mice. Young, white, male Swiss mice, weighing 18 to 20 g, were used in this study. They were housed 10 per cage and supplied Purina Mouse Chow and water ad libitum. All mice were weighed immediately before injection.Mouse leukocyte counts were performed using blood samples from the tail vein. Standard techniques of dilution using 0.1 M HOl were employed followed by enumeration of the total leukocyte ...